13th Annual BIO Investor Forum
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Sevion Therapeutics (OTCQB:SVON), a clinical stage company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, announced today that Ronald A. Martell, the Company’s Chief Executive Officer, will present at the 13th Annual BIO Investor Forum on Tuesday, October 7 at 2:00 p.m. PT at The Palace Hotel in San Francisco, CA
Help employers find you! Check out all the jobs and post your resume.
